(Q51574361)

7 April 2018

title

Carboxymethylethanolamine, a biomarker of phospholipid modification during the maillard reaction in vivo. (English)

1 reference

7 April 2018

0 references

Requena JR

1

1 reference

7 April 2018

Ahmed MU

2

1 reference

7 April 2018

Fountain CW

3

1 reference

7 April 2018

Degenhardt TP

4

1 reference

7 April 2018

Reddy S

5

1 reference

7 April 2018

Perez C

6

1 reference

7 April 2018

Lyons TJ

7

1 reference

7 April 2018

Jenkins AJ

8

1 reference

7 April 2018

Baynes JW

9

1 reference

7 April 2018

Thorpe SR

10

1 reference

7 April 2018

language of work or name

English

0 references

publication date

1 July 1997

1 reference

7 April 2018

Journal of Biological Chemistry

published in

1 reference

7 April 2018

volume

272

1 reference

7 April 2018

issue

28

1 reference

7 April 2018

page(s)

17473-17479

1 reference

7 April 2018

The Maillard reaction in vivo

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.28.17473

Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.28.17473

Role of the Maillard reaction in diabetes mellitus and diseases of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.28.17473

Accumulation of Maillard reaction products in skin collagen in diabetes and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.28.17473

Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.28.17473

Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.28.17473

Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.28.17473

Role of oxidative stress in development of complications in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.28.17473

Lipid advanced glycosylation: pathway for lipid oxidation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.28.17473

Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.28.17473

Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.28.17473

In vivo externalization of phosphatidylserine and phosphatidylethanolamine in the membrane bilayer and hypercoagulability by the lipid peroxidation of erythrocytes in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.28.17473

Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.28.17473

N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.272.28.17473

Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes

21 January 2018

1 reference

23 October 2023

https://opencitations.net/index/coci/api/v1/citations/10.2337/DIAB.38.12.1539

Identifiers

DOI

10.1074/JBC.272.28.17473

1 reference

7 April 2018

1 reference

7 April 2018